Approximately 10% of patients with CAH have CAH-X syndrome due to the presence of a monoallelic nonfunctional TNXB/TNXA chimeric gene in combination with another CYP21A2 pathogenic mutation in the second allele [2]. Here, TNXA is linked to congenital adrenal hyperplasia.